Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entinostat versus placebo plus endocrine therapy in hormone receptor-positive advanced breast cancer
CTR20200467Phase 3Active
- Sponsor
- Eddingpharm
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of entinostat in breast cancer, sponsored by Eddingpharm. Started May 2018; status: active.
02
Drugs
entinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20200467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200467.